| Product Code: ETC9975814 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Sartans Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Sartans Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Sartans Market - Industry Life Cycle |
3.4 United States (US) Sartans Market - Porter's Five Forces |
3.5 United States (US) Sartans Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 United States (US) Sartans Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 United States (US) Sartans Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United States (US) Sartans Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of hypertension and cardiovascular diseases in the US |
4.2.2 Growing awareness about the benefits of sartans in managing hypertension |
4.2.3 Technological advancements in drug delivery systems for sartans |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval and marketing |
4.3.2 Competition from alternative medications for hypertension treatment |
4.3.3 Potential side effects associated with sartans leading to safety concerns |
5 United States (US) Sartans Market Trends |
6 United States (US) Sartans Market, By Types |
6.1 United States (US) Sartans Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Sartans Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 United States (US) Sartans Market Revenues & Volume, By Valsartan, 2021- 2031F |
6.1.4 United States (US) Sartans Market Revenues & Volume, By Telmisartan, 2021- 2031F |
6.1.5 United States (US) Sartans Market Revenues & Volume, By Losartan, 2021- 2031F |
6.1.6 United States (US) Sartans Market Revenues & Volume, By Irbesartan, 2021- 2031F |
6.1.7 United States (US) Sartans Market Revenues & Volume, By Azilsartan, 2021- 2031F |
6.1.8 United States (US) Sartans Market Revenues & Volume, By Olmesartan, 2021- 2031F |
6.2 United States (US) Sartans Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Sartans Market Revenues & Volume, By Valsartan, 2021- 2031F |
6.2.3 United States (US) Sartans Market Revenues & Volume, By Telmisartan, 2021- 2031F |
6.2.4 United States (US) Sartans Market Revenues & Volume, By Losartan, 2021- 2031F |
6.2.5 United States (US) Sartans Market Revenues & Volume, By Irbesartan, 2021- 2031F |
6.2.6 United States (US) Sartans Market Revenues & Volume, By Azilsartan, 2021- 2031F |
6.2.7 United States (US) Sartans Market Revenues & Volume, By Olmesartan, 2021- 2031F |
6.3 United States (US) Sartans Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Sartans Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 United States (US) Sartans Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F |
6.3.4 United States (US) Sartans Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Sartans Market Import-Export Trade Statistics |
7.1 United States (US) Sartans Market Export to Major Countries |
7.2 United States (US) Sartans Market Imports from Major Countries |
8 United States (US) Sartans Market Key Performance Indicators |
8.1 Patient adherence rate to sartan therapy |
8.2 Number of prescriptions for sartans by healthcare providers |
8.3 Average dosage of sartans prescribed by physicians |
8.4 Rate of adoption of newer sartan formulations |
8.5 Number of reported adverse events related to sartan usage |
9 United States (US) Sartans Market - Opportunity Assessment |
9.1 United States (US) Sartans Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 United States (US) Sartans Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 United States (US) Sartans Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United States (US) Sartans Market - Competitive Landscape |
10.1 United States (US) Sartans Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Sartans Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here